smh thesundaymorningherald
Major health insurer becomes first in Australia to support medical cannabis treatments...
The announcement came the day after ASX-listed medical cannabis producer Zelira Therapeutics announced it had partnered with health clinic company Emerald Clinics to conduct observational trials for patients diagnosed with Autism Spectrum Disorder treated with Zelira's products.Zelira managing director Richard Hopkins said it would be one of the largest observational medicinal cannabis studies ever undertaken in patients with ASD involving a specific range of products.
Dream big with Zelira, page-493
Add ZLD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
70.0¢ |
Change
-0.050(6.67%) |
Mkt cap ! $7.943M | |||
| Open | High | Low | Value | Volume |
| 75.0¢ | 75.0¢ | 70.0¢ | $1.906K | 2.567K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3429 | 66.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 70.0¢ | 1056 | 1 |
View Market Depth
| Last trade - 15.30pm 08/11/2024 (20 minute delay) ? |
| ZLD (ASX) Chart |